What should you know about titrating antibodies for flow cytometry?

Flow cytometry uses labelled antibodies to recognise markers on or inside cells. During titration, the laboratory tests a planned range of antibody amounts on suitable control material and compares signal strength with unwanted background. The goal is a reproducible separation between cells that carry the marker and cells that do not.

The result can depend on the sample type, cell number, marker density, antibody clone, fluorochrome, instrument settings, and storage conditions. A concentration that works for one panel or specimen may not be suitable for another. Titration supports interpretation; it does not by itself diagnose cancer.

Patients usually do not perform the titration. Follow the preparation and collection instructions for the specimen requested, such as blood, fluid, or a sample from a procedure. Tell the clinical team about medicines and recent treatments because they may affect the cells available for testing.

If results are being used alongside a biopsy or bone marrow examination, ask how the flow findings will be combined with morphology, clinical information, and other laboratory tests. Keep the laboratory and clinic contact details in case an additional sample is needed.

Titration itself does not cause patient symptoms because it is a laboratory step. Seek care for symptoms related to the specimen collection or underlying illness, such as persistent bleeding, worsening pain, fever, fainting, or increasing redness at a collection site.

Ask which specimen is being tested, which cell markers are relevant, when results are expected, and whether the panel may need confirmation. Clarify whether treatment timing, a small sample, or poor cell preservation could limit interpretation.